Completed PHASE3 INTERVENTIONAL 4-arm NCT00574067

Buprenorphine for Prisoners

Sponsor: Friends Research Institute, Inc.

Interventions Buprenorphine +CHC Buprenorphine +OTP Counseling +CHC Counseling +OTP

Updated 8 times since 2017 Last updated: Jul 31, 2018 Started: Sep 30, 2008 Primary completion: Mar 31, 2013 Completion: Nov 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00574067, this PHASE3 trial focuses on Heroin Addiction and remains completed. Sponsored by Friends Research Institute, Inc., it has been updated 8 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE3
Jan 2021 — Dec 2022 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Sep 2018 — Jan 2021 [monthly]

Completed PHASE3
Jun 2018 — Sep 2018 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Data source: Friends Research Institute, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States
• Jessup, United States